Zhu Y - Search Results

1

Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.

Zhu Y, Lu L, Xu L, Yang H, Jiang S, Chen YH. Zhu Y, et al. J Virol. 2010 Sep;84(18):9359-68. doi: 10.1128/JVI.00644-10. Epub 2010 Jun 30. J Virol. 2010. PMID: 20592080 Free PMC article.

2

Important changes in biochemical properties and function of mutated LLP12 domain of HIV-1 gp41.

Zhu Y, Lu L, Chao L, Chen YH. Zhu Y, et al. Chem Biol Drug Des. 2007 Oct;70(4):311-8. doi: 10.1111/j.1747-0285.2007.00564.x. Epub 2007 Sep 10. Chem Biol Drug Des. 2007. PMID: 17850282 Free PMC article.

3

V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.

Lu L, Zhu Y, Diao J, Wang Z, Chen YH. Lu L, et al. Among authors: zhu y. Vaccine. 2008 Feb 6;26(6):845-52. doi: 10.1016/j.vaccine.2007.11.022. Epub 2007 Nov 29. Vaccine. 2008. PMID: 18191003

4

Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core.

Lu L, Zhu Y, Huang J, Chen X, Yang H, Jiang S, Chen YH. Lu L, et al. Among authors: zhu y. J Biol Chem. 2008 Jun 13;283(24):16723-31. doi: 10.1074/jbc.M801083200. Epub 2008 Apr 11. J Biol Chem. 2008. PMID: 18408000 Free PMC article.

5

Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.

Chao L, Lu L, Yang H, Zhu Y, Li Y, Wang Q, Yu X, Jiang S, Chen YH. Chao L, et al. Among authors: zhu y. PLoS One. 2013 May 31;8(5):e66156. doi: 10.1371/journal.pone.0066156. Print 2013. PLoS One. 2013. PMID: 23741527 Free PMC article.

6

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.

Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. Lu L, et al. Among authors: zhu y. Nat Commun. 2014;5:3067. doi: 10.1038/ncomms4067. Nat Commun. 2014. PMID: 24473083 Free PMC article.

7

P20A inhibits HIV-1 fusion through its electrostatic interaction with the distal region of the gp41 fusion core.

Fu S, Tong P, Tan Y, Zhu Y, Chen YH. Fu S, et al. Among authors: zhu y. Microbes Infect. 2015 Sep;17(9):665-70. doi: 10.1016/j.micinf.2015.05.003. Epub 2015 May 21. Microbes Infect. 2015. PMID: 26003522 Free article.

8

Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy.

Zhu X, Zhu Y, Ye S, Wang Q, Xu W, Su S, Sun Z, Yu F, Liu Q, Wang C, Zhang T, Zhang Z, Zhang X, Xu J, Du L, Liu K, Lu L, Zhang R, Jiang S. Zhu X, et al. Among authors: zhu y. Sci Rep. 2015 Aug 19;5:13028. doi: 10.1038/srep13028. Sci Rep. 2015. PMID: 26286358 Free PMC article.

9

A randomized open-label clinical trial of an anti-HPV biological dressing (JB01-BD) administered intravaginally to treat high-risk HPV infection.

Guo X, Qiu L, Wang Y, Wang Y, Wang Q, Song L, Li Y, Huang K, Du X, Fan W, Jiang S, Wang Q, Li H, Yang Y, Meng Y, Zhu Y, Lu L, Jiang S. Guo X, et al. Among authors: zhu y. Microbes Infect. 2016 Feb;18(2):148-52. doi: 10.1016/j.micinf.2015.10.004. Epub 2015 Oct 24. Microbes Infect. 2016. PMID: 26506570 Free article. Clinical Trial.

10

Safety evaluation of chemically modified beta-lactoglobulin administered intravaginally.

Guo X, Qiu L, Wang Y, Wang Y, Meng Y, Zhu Y, Lu L, Jiang S. Guo X, et al. Among authors: zhu y. J Med Virol. 2016 Jun;88(6):1098-101. doi: 10.1002/jmv.24439. Epub 2016 Jan 5. J Med Virol. 2016. PMID: 26629967 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54,737 results

Search Page

Filters